Bioorganic & Medicinal Chemistry Letters 16 (2006) 1702–1706
Synthesis and insecticidal activity of fluorinated
2-(2,6-dichloro-4-trifluoromethylphenyl)-2,4,5,6-
tetrahydrocyclopentapyrazoles
Sanath K. Meegalla,a,* Dario Doller,a Ruiping Liu,a DeYou Sha,a YuKai Lee,a
Richard M. Soll,a Nancy Wisnewski,b Gary M. Silverb and Dale Dhanoaa
aJohnson & Johnson Pharmaceutical Research and Development, 665 Stockton Drive, Suite 104, Exton, PA 19341, USA
bHeska Corporation, 1613 Prospect Parkway, Fort Collins, CO 80525, USA
Received 9 September 2005; revised 2 December 2005; accepted 2 December 2005
Available online 28 December 2005
Abstract—A number of fluorinated 1-aryl-tetrahydrocyclopentapyrazoles were synthesized and their insecticidal activity was eval-
uated. Some of the fluorinated compounds had significant insecticidal properties.
Ó 2005 Elsevier Ltd. All rights reserved.
Prior to 1995, a large proportion of market sales in the
area of animal flea-killing agents came from generic,
‘over-the-counter’ drugs. In the late 1990s’ three new
anti-flea products drove market sales to veterinarians.
These products are: ProgramTM (Novartis, 1995),
AdvantageTM (Bayer, 1996), and FrontlineTM (Rhone-
Merieux Merial, 1996).
More specifically, we became interested in 2-(2,6-
dichloro-4-trifluoromethylphenyl)-2,4,5,6-tetrahydrocy-
clopentapyrazoles (5) and 2-(2,6-dichloro-4-trifluorom-
ethylphenyl)-4-methyl-2,4,5,6-tetrahydrocyclopentapy-
razoles (6), which showed good binding affinity for the
GABA receptor in housefly brain preparations (83
and 30 nM, respectively), with 19- and 126-fold selec-
tivity against mammalian GABA receptors, respective-
ly. Although 5 and 6 caused only 30% and 10%
mortality in a housefly contact assay, respectively,
both compounds produced high mortality in three flea
strains tested (Table 1).
The active pharmaceutical ingredient in each of these
three products has a different mechanism of action.
Lufenuron (1), the active ingredient of ProgramTM, is
a chitin synthesis/polymerization inhibitor. Bayer’s
anti-flea agent AdvantageTM contains imidacloprid (2),
which is a nicotinic acetylcholine receptor agonist. The
active ingredient of FrontlineTM is fipronil (3), a phen-
ylpyrazole which acts as a GABA-gated chloride chan-
nel inhibitor which causes hyperactivity in neurons,
leading to eventual death.
Unfortunately, compounds 5 and 6 were ineffective as
anti-flea agents in in vivo efficacy studies in dogs after
either topical (10 mg/kg) or oral (20 mg/kg) administra-
tion. Although dogs orally dosed with compound 5 had
quantifiable levels of compound in plasma for as long as
3 h post-dosing, only trace plasma levels of 5 were
detected after topical dosing over a comparable period
of time. In vivo metabolite identification studies, carried
out by LC/MS/MS analysis of plasma samples from
dogs that had been orally dosed with compound 5, re-
vealed that the test article was extensively hydroxylated
at benzylic positions 4 and 6. In agreement with this
observation, in vitro metabolic stability studies on 5
showed it had a short half-life (t1/2 = 2.5 min) in dog
liver microsomal preparations (unpublished data).
Recently, we described1 the synthesis and structure–in-
secticidal activity relationships of a series of 3,4-fused-
cycloalkyl-1-arylpyrazoles (generic structure 4). These
could be formally considered as rotationally constrained
analogs of fipronil (3).
Keywords: Phenylpyrazole; GABA; Fipronil; Anti-flea; Anti-Tick.
*
Thestructure–insecticidalbindingaffinitystudies(unpub-
lished data) in this series of compounds demonstrated
Corresponding author. Tel.: +1 610 458 8959; e-mail: smeegall@
0960-894X/$ - see front matter Ó 2005 Elsevier Ltd. All rights reserved.
doi:10.1016/j.bmcl.2005.12.012